Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma

Cancer Research

Volumn 68, Issue 24, 2008, Pages 10300-10306

  Solomon, David A ^a   Kim, Jung Sik ^a   Cronin, Julia C ^c   Sibenaller, Zita ^e   Ryken, Timothy ^e   Rosenberg, Steven A ^d   Ressom, Habtom ^a   Jean, Walter ^b   Bigner, Darell ^f   Yan, Hai ^f   Samuels, Yardena ^c   Waldman, Todd ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CHROMOSOME 9P; CONTROLLED STUDY; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PTPRD GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 9; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MELANOMA; MICE; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; TRANSPLANTATION, HETEROLOGOUS;

EID: 57749106582     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3272     Document Type: Article

References (29)

1. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13.
2. Wang Z, Shen D, Parsons DW, et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004;304:1164-6.
3. Ostman A, Hellberg C, Bohmer FD. Protein-tyrosine phosphatases and cancer. Nature Rev Cancer 2006;6:307-20.
4. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006;7:833-46.
5. Cox C, Bignell G, Greenman C, et al. A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci U S A 2005;102:4542-7.
6. Sato M, Takahashi K, Nagayama K, et al. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 2005;44:405-14.
7. Stallings RL, Nair P, Maris JM, et al. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 2006;66:3673-80.
8. Stark M, Hayward N. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 2007;67:2632-42.
9. Purdie KJ, Lambert SR, Teh MT, et al. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 2007;46:661-9.
10. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD, Yokota J. Homozygous deletion scanning of the lung cancer genome at 100-kb resolution. Genes Chromosomes Cancer 2007;46:1000-10.
11. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-8.
12. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74.
13. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98:31-6.
14. INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Res 2008;68:2564-9.
15. Wiedemeyer R, Brennan C, Heffernan TP, et al. Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell 2008;13:355-64.
16. Ueki K, Rubio MP, Ramesh V, et al. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 1994;3:1841-5.
17. Puig S, Ruiz A, Lázaro C, et al. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am J Hum Genet 1995;57:395-402.
18. Kim SK, Ro JY, Kemp BL, et al. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 1997;57:400-3.
19. Pollock PM, Welch J, Hayward NK. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res 2001;61:1154-61.
20. Cook AL, Pollock PM, Welch J, et al. CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin. Int J Cancer 2001;93:361-7.
21. Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanomas. J Clin Oncol 2007;25:1606-20.
22. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;355:2135-47.
23. Pulido R, Krueger NX, Serra-Pages C, Saito H, Streuli M. Molecular characterization of the human transmembrane protein-tyrosine phosphatase δ. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase δ isoforms. J Biol Chem 1995;270:6722-8.
24. Aricescu AR, Siebold C, Choudhuri K, et al. Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science 2007;317:1217-20.
25. Gebbink MF, Zondag GC, Wubbolts RW, Beijersbergen RL, van Etten I, Moolenaar WH. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J Biol Chem 1993;268:16101-4.
26. Sommer L, Rao M, Anderson DJ. RPTPδ and the novel protein tyrosine phosphatase RPTPψ are expressed in restricted regions of the developing central nervous system. Dev Dyn 1997;208:48-61.
27. Thiery JP. Cell adhesion in development: a complex signaling network. Curr Opin Genet Dev 2003;13:365-71.
28. Uetani N, Kato K, Ogura H, et al. Impaired learning with enhanced hippocampus long-term potentiation in PTPδ-deficient mice. EMBO J 2000;19:2775-85.
29. Wang J, Bixby JL. Receptor tyrosine phosphatase-δ is a homophilic, neurite-promoting cell adhesion molecule for CNS neurons. Mol Cell Neurosci 1999;14:370-84.